Doctors and menopausal women have different opinions about HRT. The Women’s Health Initiative information influences women’s attitudes toward HRT. Its published associated risks, like breast cancer, heart disease, stroke, and blood clots make women and doctors hesitant to use HRT for menopause treatment. As a result, the percentage of menopausal women using hormone replacement therapy declined yearly by 0.23% (from 2007 to 2023).  However, a part of this statistic doesn’t come from HRT’s associated health risks. Some menopausal women have existing health conditions and health histories that keep them from trying HRT. Here are some: 1. Breast Cancer Women with a history of breast cancer are advised against using HRT. Estrogen stimulates the growth of some breast cancer cells and increases the risk of cancer recurrence. For example, a woman previously treated for estrogen receptor-positive breast cancer will have a heightened risk if she undergoes HRT. A 2021 review published in Brea...

  Tibolone is a synthetic steroid hormone that has estrogen, androgen, and progestogen properties. It restores the imbalanced female hormones during menopause and manages night sweats and hot flashes. Also, this is prescribed to women who missed their periods for a year to prevent osteoporosis. Tibolone is produced by Organon Pharmaceuticals in West Orange, New Jersey. It comes in tablets and has been used in Europe for 2 decades as treatment and prevention of postmenopausal osteoporosis and postmenopausal symptoms. Additionally, it is approved in 90 countries to manage menopause symptoms and in 45 countries to prevent osteoporosis development. Regulation The FDA didn’t approve tibolone for use in the United States (Organon Pharmaceuticals received a ‘Not Approvable’ letter from the FDA). The treatment’s increased breast cancer and stroke risks, and its androgenic effects (it can act like male hormones in the body) are the factors contributed to FDAs decision. Tibolone is approved ...

Transdermal menopause hormone therapy is administered through the skin using patches, gels, creams, and sprays. This treatment absorbs estrogen and sometimes progestin (if necessary) directly into the bloodstream. The hormones penetrate the skin barrier and enter the blood vessels, ensuring a steady absorption into the bloodstream. It's available in: Patches Applied on a clean and dry skin of the lower abdomen, upper thighs, and buttocks. Changed according to the prescribed schedule. Gel and Cream Applied daily on arms, legs, shoulders, or abdomen. Requires drying time before covering with clothing to ensure proper absorption. Spray Applied daily through metered-dose spray on the forearm (between the elbow and the wrist) and inner thigh. Requires drying time before covering with clothing to ensure proper absorption. Transdermal Efficacy Transdermal menopause hormone therapy benefits the liver and digestive system because it bypasses first-pass metabolism in the liver and avoids dir...

Progesterone treatment provides a balanced approach to menopause medication, particularly when estrogen therapy is involved. It is proven that estrogen alone thickens lining, which increases the risk of endometrial cancer.  Progesterone treatment case studies highlight the capacity of progesterone HRT in treating some menopause symptoms. Also, it provides valuable information about its practical application and individual responses to progesterone in menopause treatment. 1. Hot Flashes and Night Sweats A randomized controlled trial that lasted 12 weeks had 133 healthy postmenopausal women aged 44 to 62 years. They were 1 to 10 years after their final menstruation. Participants were administered 300 mg of oral micronized progesterone daily at bedtime. The mean daily VMS (vasomotor symptoms) score decreased by 10.0 points in the progesterone group compared to a 4.4-point reduction in the placebo group. This showed that oral micronized progesterone effectively reduced the severity and...